Serum 25-Hydroxyvitamin D Concentration and Subsequent Risk of Type 2 Diabetes
dc.contributor.author | MATTILA, CATHARINA | |
dc.contributor.author | KNEKT, PAUL | |
dc.contributor.author | MANNISTO, SATU | |
dc.contributor.author | RISSANEN, HARRI | |
dc.contributor.author | LAAKSONEN, MAARIT A. | |
dc.contributor.author | MONTONEN, JUKKA | |
dc.contributor.author | REUNANEN, ANTTI | |
dc.date.accessioned | 2019-08-14T15:00:46Z | |
dc.date.available | 2019-08-14T15:00:46Z | |
dc.date.issued | 2007 | |
dc.description.abstract | It has been suggested that vitamin D reduces the risk of type 2 diabetes. The finding that vitamin D deficiency is associated with impaired -cell function and insulin resistance in animals (1,2) and humans (3,4) is in line with that hypothesis. In the only cohort study published, the intake of vitamin D supplements was inversely associated with the development of type 2 diabetes (5). Since vitamin D intake covers only a part of the total vitamin D available, the purpose of this study was to evaluate the prediction of serum 25-hydroxyvitaminD (25OHD) on | |
dc.description.uri | https://care.diabetesjournals.org/content/30/10/2569 | |
dc.identifier | https://doi.org/10.13016/5lja-k9vh | |
dc.identifier.citation | MATTILA, CATHARINA and KNEKT, PAUL and MANNISTO, SATU and RISSANEN, HARRI and LAAKSONEN, MAARIT A. and MONTONEN, JUKKA and REUNANEN, ANTTI (2007) Serum 25-Hydroxyvitamin D Concentration and Subsequent Risk of Type 2 Diabetes. DIABETES CARE, 30 (10). pp. 2569-2570. | |
dc.identifier.other | Eprint ID 883 | |
dc.identifier.uri | http://hdl.handle.net/1903/22848 | |
dc.subject | Diabetes | |
dc.subject | studies | |
dc.subject | vitamin D | |
dc.subject | type 2 diabetes | |
dc.subject | vitamin D deficiency | |
dc.subject | insulin resistance | |
dc.title | Serum 25-Hydroxyvitamin D Concentration and Subsequent Risk of Type 2 Diabetes | |
dc.type | Article |